Ewida MA - Search Results

1

Discovery of pyrazole-based analogs as CDK2 inhibitors with apoptotic-inducing activity: design, synthesis and molecular dynamics study.

Ali GME, Ewida MA, Elmetwali AM, Ewida HA, George RF, Mahmoud WR, Ismail NSM, Ahmed MS, Georgey HH. Ali GME, et al. Among authors: ewida ma. RSC Adv. 2024 Oct 29;14(47):34537-34555. doi: 10.1039/d4ra06500j. eCollection 2024 Oct 29. RSC Adv. 2024. PMID: 39479486 Free PMC article.

2

Newly Synthesized Anticancer Purine Derivatives Inhibiting p-EIF4E Using Surface-Modified Lipid Nanovesicles.

Attia RT, Ewida MA, Khaled E, Fahmy SA, Fawzy IM. Attia RT, et al. Among authors: ewida ma. ACS Omega. 2023 Oct 6;8(41):37864-37881. doi: 10.1021/acsomega.3c02991. eCollection 2023 Oct 17. ACS Omega. 2023. PMID: 37867723 Free PMC article.

3

Development of pyrolo[2,3-c]pyrazole, pyrolo[2,3-d]pyrimidine and their bioisosteres as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological evaluation and molecular dynamics investigations.

Azmy EM, Hagras M, Ewida MA, Doghish AS, Gamil Khidr E, El-Husseiny AA, Gomaa MH, Refaat HM, Ismail NSM, Nassar IF, Lashin WH. Azmy EM, et al. Among authors: ewida ma. Bioorg Chem. 2023 Oct;139:106729. doi: 10.1016/j.bioorg.2023.106729. Epub 2023 Jul 13. Bioorg Chem. 2023. PMID: 37467621

4

Experimental and Computational Analysis of Newly Synthesized Benzotriazinone Sulfonamides as Alpha-Glucosidase Inhibitors.

Khalid Z, Alnuwaiser MA, Ahmad HA, Shafqat SS, Munawar MA, Kamran K, Abbas MM, Kalam MA, Ewida MA. Khalid Z, et al. Among authors: ewida ma. Molecules. 2022 Oct 11;27(20):6783. doi: 10.3390/molecules27206783. Molecules. 2022. PMID: 36296403 Free PMC article.

5

3-Methyl-imidazo[2,1-b]thiazole derivatives as a new class of antifolates: Synthesis, in vitro/in vivo bio-evaluation and molecular modeling simulations.

Ewida MA, Ewida HA, Ahmed MS, Allam HA, ElBagary RI, George RF, Georgey HH, El-Subbagh HI. Ewida MA, et al. Bioorg Chem. 2021 Oct;115:105205. doi: 10.1016/j.bioorg.2021.105205. Epub 2021 Jul 24. Bioorg Chem. 2021. PMID: 34329992

6

Nanomolar potency of imidazo[2,1-b]thiazole analogs as indoleamine 2,3-dioxygenase inhibitors.

Ewida MA, Ewida HA, Ahmed MS, Allam HA, ElBagary RI, George RF, Georgey HH, El-Subbagh HI. Ewida MA, et al. Arch Pharm (Weinheim). 2021 Nov;354(11):e2100202. doi: 10.1002/ardp.202100202. Epub 2021 Jul 27. Arch Pharm (Weinheim). 2021. PMID: 34313342

7

Imidazo[2',1':2,3]thiazolo[4,5-d]pyridazinone as a new scaffold of DHFR inhibitors: Synthesis, biological evaluation and molecular modeling study.

Ewida MA, Abou El Ella DA, Lasheen DS, Ewida HA, El-Gazzar YI, El-Subbagh HI. Ewida MA, et al. Bioorg Chem. 2018 Oct;80:11-23. doi: 10.1016/j.bioorg.2018.05.025. Epub 2018 May 26. Bioorg Chem. 2018. PMID: 29864684

8

Thiazolo[4,5-d]pyridazine analogues as a new class of dihydrofolate reductase (DHFR) inhibitors: Synthesis, biological evaluation and molecular modeling study.

Ewida MA, Abou El Ella DA, Lasheen DS, Ewida HA, El-Gazzar YI, El-Subbagh HI. Ewida MA, et al. Bioorg Chem. 2017 Oct;74:228-237. doi: 10.1016/j.bioorg.2017.08.010. Epub 2017 Aug 24. Bioorg Chem. 2017. PMID: 28865294

9

Synthesis, biological evaluation and molecular modeling study of new (1,2,4-triazole or 1,3,4-thiadiazole)-methylthio-derivatives of quinazolin-4(3H)-one as DHFR inhibitors.

El-Gazzar YI, Georgey HH, El-Messery SM, Ewida HA, Hassan GS, Raafat MM, Ewida MA, El-Subbagh HI. El-Gazzar YI, et al. Among authors: ewida ma. Bioorg Chem. 2017 Jun;72:282-292. doi: 10.1016/j.bioorg.2017.04.019. Epub 2017 May 4. Bioorg Chem. 2017. PMID: 28499189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters